CVRx, Inc. - Common Stock, $0.01 par value (CVRX)

CUSIP: 126638105

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-1,368,264
Put/Call ratio
77%
SEC-reported price per share
$5.88
Number of holders
91
Value change
-$19,986,146
Number of buys
55
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
26,135,461

Security key

126638105

Report period

Q2 2025

Institutions

91

Top holders

10

Ownership snapshot

Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NEW ENTERPRISE ASSOCIATES...
Disclosed value leader
JOHNSON & JOHNSON
Comparable rows
15/15
Latest evidence
31 Mar 2025
3/4/5 13D/G 13F Lead comparable stake: 7.8% 13D/G row: NEW ENTERPRISE ASSOCIATES 10 L P Showing 1-6 of 15 holder rows.

Quick read

NEW ENTERPRISE ASSOCIATES 10 L P leads the comparable SEC ownership view at 7.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEW ENTERPRISE ASSOCIATES 10 L P's linked filing trail.
Comparable ownership Top 5
NEW ENTERPRISE ASSOCIATES 10 L P 7.8%
Vensana Capital I GP, LLC 7.2%
Gilde Healthcare IV U.a. Cooperat... 4.9%
JOHNSON & JOHNSON 16%
NEA Management Company, LLC 7.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NEW ENTERPRISE ASSOCIATES 10 L P
3/4/5 13D/G
10%+ Owner · New Enterprise Associates 10, Limited Partnership
7.8%
from 13D/G
$37,593,767
2,026,083 shares
02 Jul 2021
Vensana Capital I GP, LLC
13D/G
Kirk Nielsen
7.2%
$11,849,740
1,760,734 shares
$0 31 Dec 2024
Gilde Healthcare IV U.a. Cooperatieve
13D/G
Cooperatieve Gilde Healthcare IV U.A.
4.9%
$8,287,928
1,231,490 shares
$0 04 Feb 2025
JOHNSON & JOHNSON
13F
Company
13F
16%
$50,184,949
4,103,430 shares
31 Mar 2025
NEA Management Company, LLC
13F
Company
13F
7.8%
$24,778,995
2,026,083 shares
31 Mar 2025
Parkman Healthcare Partners LLC
13F
Company
13F
4.7%
$15,037,054
1,229,522 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
91
Shares
14,566,804
Rows available
91
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
95
Q2 2025 holders
91
Holder diff
-4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .